Published in Lancet on August 30, 1986
Nephron supply is a major determinant of long-term renal allograft outcome in rats. J Clin Invest (1994) 0.93
Long-term kidney isografts develop functional and morphologic changes that mimic those of chronic allograft rejection. Ann Surg (1994) 0.93
Causes of renal allograft loss. Progress in the 1980s, challenges for the 1990s. Ann Surg (1991) 0.87
The late results of renal transplantation and the importance of chronic rejection as a cause of graft loss. Ann R Coll Surg Engl (1989) 0.84
Characteristics of cadaveric renal allograft recipients developing chronic rejection. Ann R Coll Surg Engl (1990) 0.83
Chronic allograft failure in human renal transplantation: a multivariate risk factor analysis. Ann Surg (2000) 0.77
Isolated microscopic haematuria in the genitourinary clinic: the value of renal biopsy. Int J STD AIDS (1997) 2.02
Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: observations in three patients. Kidney Int (2001) 1.99
Treatment of IgA nephropathy. Kidney Int (2006) 1.98
Fulminant psittacosis. Lancet (1979) 1.94
Serum 1,25-dihydroxyvitamin D may be related inversely to disease activity in breast cancer patients with bone metastases. J Clin Endocrinol Metab (1997) 1.79
Increased incidence of end-stage renal failure secondary to diabetes mellitus in Asian ethnic groups in the United Kingdom. Diabet Med (1992) 1.79
Glomerular disease as a cause of isolated microscopic haematuria. Q J Med (1994) 1.70
High incidence of end-stage renal disease in Indo-Asians in the UK. QJM (1995) 1.68
Galactosylation of N- and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy. Clin Exp Immunol (1995) 1.66
End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link? Kidney Int (2001) 1.61
Seroprevalence of human granulocytic ehrlichiosis among permanent residents of northwestern Wisconsin. Clin Infect Dis (1998) 1.54
High incidence of minimal change nephrotic syndrome in Asians. Arch Dis Child (1985) 1.51
Increased immunoglobulin A and immunoglobulin A1 cells in bone marrow trephine biopsy specimens in immunoglobulin A nephropathy. Am J Kidney Dis (1994) 1.50
c-erbB-2 oncoprotein overexpression in uterine cervix carcinoma with glandular differentiation. A frequent event but not an independent prognostic marker because it occurs late in the disease. Am J Clin Pathol (1995) 1.47
Parathyroidectomy in chronic renal failure: comparison of three operative strategies. J R Coll Surg Edinb (1996) 1.44
Elevation of IgA in IgA nephropathy is localized in the serum and not saliva and is restricted to the IgA1 subclass. Nephrol Dial Transplant (1993) 1.43
Pathophysiology of cyclosporin A nephrotoxicity: experimental and clinical observations. Nephrol Dial Transplant (1992) 1.43
Activation of the adenovirus and BK virus late promoters: effects of the BK virus enhancer and trans-acting viral early proteins. Mol Cell Biol (1986) 1.40
Vascular access for chronic haemodialysis. Lancet (1989) 1.39
The third World Kidney Day: looking back and thinking forward. Clin Nephrol (2008) 1.39
The correlation between Kt/V and protein catabolic rate--a self-fulfilling prophecy. Nephrol Dial Transplant (1994) 1.39
The role of proteinuria in the progression of chronic renal failure. Am J Kidney Dis (1996) 1.39
Plasma erythropoietin levels and acquired cystic disease of the kidney in patients receiving regular haemodialysis treatment. Br J Haematol (1991) 1.38
Glucose polymer for ultrafiltration failure in CAPD. Lancet (1993) 1.38
A comparison of the results of renal transplantation from non-heart-beating, conventional cadaveric, and living donors. Kidney Int (2000) 1.35
WRN helicase expression in Werner syndrome cell lines. Nucleic Acids Res (2000) 1.32
IgA nephropathy: recent developments. J Am Soc Nephrol (2000) 1.31
Diabetic renal disease: differences between Asian and white patients. Br Med J (Clin Res Ed) (1986) 1.29
Immunological aspects of acute ureteral obstruction: immune cell infiltrate in the kidney. Kidney Int (1988) 1.22
Characterization of the 5' to 3' exonuclease associated with Thermus aquaticus DNA polymerase. Nucleic Acids Res (1990) 1.22
Role of an improvement in acid-base status and nutrition in CAPD patients. Kidney Int (1997) 1.22
Uracil-excision DNA repair. Prog Nucleic Acid Res Mol Biol (1994) 1.21
Leucocyte beta 1,3 galactosyltransferase activity in IgA nephropathy. Nephrol Dial Transplant (1997) 1.21
Abnormal IgA glycosylation in Henoch-Schönlein purpura restricted to patients with clinical nephritis. Nephrol Dial Transplant (1998) 1.19
Selection-adjusted comparison of life-expectancy of patients on continuous ambulatory peritoneal dialysis, haemodialysis, and renal transplantation. Lancet (1987) 1.19
Hyperparathyroidism in chronic renal failure and dialysis osteodystrophy. Q J Med (1970) 1.15
Physical exercise in patients with severe kidney disease. Nephron Clin Pract (2010) 1.12
Association of p53 and WAF1 expression with apoptosis in diffuse alveolar damage. Am J Pathol (1996) 1.11
High prevalence of systemic disease and mortality in Asian subjects with systemic lupus erythematosus. Ann Rheum Dis (1991) 1.10
Low protein diets in uraemia. Br Med J (Clin Res Ed) (1983) 1.09
IgA myeloma presenting as Henoch-Schönlein purpura with nephritis. Am J Kidney Dis (2000) 1.06
Analysis of IgA1 O-glycans in IgA nephropathy by fluorophore-assisted carbohydrate electrophoresis. J Am Soc Nephrol (1999) 1.06
Proteinuria induces tubular cell turnover: A potential mechanism for tubular atrophy. Kidney Int (1999) 1.05
Receptor-mediated endocytosis of albumin by kidney proximal tubule cells is regulated by phosphatidylinositide 3-kinase. J Clin Invest (1998) 1.04
Inactivation of DNA mismatch repair by increased expression of yeast MLH1. Mol Cell Biol (2001) 1.03
RCPE UK consensus conference statement: Management of acute kidney injury: the role of fluids, e-alerts and biomarkers. J R Coll Physicians Edinb (2013) 1.02
Human immune response to Pseudomonas aeruginosa mucoid exopolysaccharide (alginate) vaccine. Infect Immun (1994) 1.01
Decreased lung capillary blood volume post-exercise is compensated by increased membrane diffusing capacity. Eur J Appl Physiol (2004) 1.01
Increased dimeric IgA producing B cells in the bone marrow in IgA nephropathy determined by in situ hybridisation for J chain mRNA. J Clin Pathol (1996) 1.00
Antineutrophil cytoplasm antibodies (ANCA) of IgA isotype in adult Henoch-Schönlein purpura. Clin Exp Immunol (1994) 1.00
Influence of allograft size to recipient body-weight ratio on the long-term outcome of renal transplantation. Br J Surg (2000) 1.00
Systemic vasculitis in the 1980s--is there an increasing incidence of Wegener's granulomatosis and microscopic polyarteritis? J R Coll Physicians Lond (1990) 0.99
Structural analysis and immunogenicity of Pseudomonas aeruginosa immunotype 2 high molecular weight polysaccharide. J Clin Invest (1986) 0.99
Glomerular IgA deposition in liver disease. Nephrol Dial Transplant (1999) 0.99
Macrophages promote prosclerotic responses in cultured rat mesangial cells: a mechanism for the initiation of glomerulosclerosis. J Am Soc Nephrol (1997) 0.98
Sequential study of the IgA system in relapsing IgA nephropathy. Kidney Int (1986) 0.98
Modulation of cellular immune function by cyclophosphamide in children with minimal-change nephropathy. N Engl J Med (1984) 0.98
Primary hyperoxaluria in adult siblings: with some observations on the role of regular haemodialysis therapy. Br J Urol (1969) 0.97
Treatment and outcome of adult patients with primary focal segmental glomerulosclerosis in five UK renal units. QJM (2005) 0.96
Skeletal muscle degradation and nitrogen wasting in rats with chronic metabolic acidosis. Clin Sci (Lond) (1991) 0.95
Vascular endothelial growth factor mRNA expression in minimal change, membranous, and diabetic nephropathy demonstrated by non-isotopic in situ hybridisation. J Clin Pathol (1999) 0.95
B-cell O-galactosyltransferase activity, and expression of O-glycosylation genes in bone marrow in IgA nephropathy. Kidney Int (2008) 0.95
Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis. Kidney Int (2001) 0.95
Gm allotypes in membranous nephropathy. N Engl J Med (1983) 0.94
Alterations in lipid and carbohydrate metabolism attributable to cyclosporin A in renal transplant recipients. Br Med J (Clin Res Ed) (1986) 0.94
Mutation of an active site residue in Escherichia coli uracil-DNA glycosylase: effect on DNA binding, uracil inhibition and catalysis. Biochemistry (1999) 0.94
The role of omentectomy in continuous ambulatory peritoneal dialysis. Perit Dial Int (1991) 0.93
The prevalence of diagnosed systemic lupus erythematosus in whites and Indian Asian immigrants in Leicester city, UK. Br J Rheumatol (1992) 0.93
Metabolic acidosis does not contribute to chronic renal injury in the rat. Clin Sci (Lond) (1995) 0.93
Continuing clinically severe vitamin D deficiency in Asians in the UK (Leicester). Postgrad Med J (1994) 0.93
Impaired system A amino acid transport mimics the catabolic effects of acid in L6 cells. Eur J Clin Invest (2002) 0.93
Expression of J chain mRNA in duodenal IgA plasma cells in IgA nephropathy. Kidney Int (1994) 0.93
A selection adjusted comparison of hospitalization on continuous ambulatory peritoneal dialysis and haemodialysis. J Clin Epidemiol (1989) 0.93
Blood flow in arteriovenous shunts: observations and measurements. Br Med J (1968) 0.93
Primary tuberculosis of the esophagus. Am J Gastroenterol (1984) 0.92
Semiautomatic quantitation of macrophages in human renal biopsy specimens in proteinuric states. J Clin Pathol (1997) 0.92
Characteristics of albumin binding to opossum kidney cells and identification of potential receptors. Pflugers Arch (1997) 0.92
Effects of acetazolamide on the urinary excretion of cyclic AMP and on the activity of renal adenyl cyclase. J Clin Invest (1974) 0.92
Chronic renal failure; an important feature of the Laurence-Moon-Biedl syndrome. Postgrad Med J (1988) 0.91
Asymptomatic microscopical haematuria. Br Med J (Clin Res Ed) (1986) 0.91
Correcting impotence in the male dialysis patient: experience with testosterone replacement and vacuum tumescence therapy. Am J Kidney Dis (1998) 0.90
Renal cortical release of a specific macrophage chemoattractant in response to ureteral obstruction. Lab Invest (1990) 0.90